(Total Views: 160)
Posted On: 06/05/2023 2:40:47 PM
Post# of 92

$AVDL News Article - Avadel Pharmaceuticals Announces U.S. Commercial Launch of LUMRYZ(TM) (sodium oxybate) for the Treatment of Cataplexy or Excessive Daytime Sleepiness in Adults Living with Narcolepsy https://marketwirenews.com/news-releases/avad...69744.html


My Twitter: WhyteStocks